LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Quick Stats
Feb 03, 202643.9
AI Score
HOLD0.57
Volume Ratio
Mar 18, 2026
Next Earnings
12
+ve Days (30d)
17
-ve Days (30d)
LENZ Stock Summary
Last updated Feb 03, 2026
LENZ is currently trading at $15.53, positioned below its 200-day moving average of $30.15, suggesting bearish momentum. The stock has a 52-week range of $14.43 to $50.4.
Technical Analysis: The 50-day moving average stands at $20.65, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.771, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.04, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LENZ at 43.9/100 with a HOLD recommendation.
LENZ (LENZ Therapeutics, Inc. Common Stock) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.771 |
| CMF (20) | -0.04 |
| ROC (10) | -21.104 |
| ADX (14) | 25.912 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.703 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -93.872 |
| MFI (14) | 55.031 |
LENZ Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LENZ Price vs Max Options Open Interest
LENZ Max Change In Options Open Interest
LENZ Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LENZ Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LENZ Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LENZ Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LENZ Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LENZ Moving Averages Analysis
LENZ (LENZ Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 18.47 |
| 20 | 17.73 |
| 30 | 17.41 |
| 50 | 20.65 |
| 100 | 28.4 |
| 200 | 30.15 |
LENZ Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 495.0 million |
| Earnings/Share ($) | -2.06 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.5849 |
| EPS Estimate Next Year ($) | -2.9843 |
| WallStreet Target Price ($) | 53.7143 |
| Most Recent Quarter |